A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes

NCT07351058 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

1600

Enrollment

INDUSTRY

Sponsor class

Conditions

Obesity or Overweight
Type 2 Diabetes Mellitus

Interventions

COMBINATION_PRODUCT: Placebo
COMBINATION_PRODUCT: Enicepatide

Sponsor

Hoffmann-La Roche